BOYD-KIRKUP J D ET AL: "Integrative immune profiling of syngeneic tumor models provides predictive immune signatures for treatment response with HMBD002, a novel anti- VISTA neutralizing antibody", CANCER RESEARCH 20180701 AMERICAN ASSOCIATION FOR CANCER RESEARCH INC. NLD, vol. 78, no. 13, Supplement 1, 14 April 2018 (2018-04-14), XP009512998, ISSN: 1538-7445 (B1)

ELIZABETH C. NOWAK ET AL: "Immunoregulatory functions of VISTA", IMMUNOLOGICAL REVIEWS., vol. 276, no. 1, 1 March 2017 (2017-03-01) , pages 66-79, XP055488126, US ISSN: 0105-2896, DOI: 10.1111/imr.12525 (B1)

INGRAM PIERS J ET AL: "HMBD002, a novel neutralizing antibody targeting a specific epitope on the co-inhibitory immune checkpoint receptor VISTA, displays potent anti-tumor effects in pre-clinical models", CANCER RESEARCH, vol. 77, no. Suppl. 13, July 2017 (2017-07), page 587, XP009512999, & ANNUAL MEETING OF THE AMERICAN-ASSOCIATION-FOR-CANCER-RESEARCH (AACR); WASHINGTON, DC, USA; APRIL 01 -05, 2017 (B1)

JENSEN S M ET AL: "Anti-VISTA antibody enhances the anti-tumor immune response in mice with mammary tumors", EUROPEAN JOURNAL OF IMMUNOLOGY, vol. 46, no. Suppl. 1, Sp. Iss. SI, August 2016 (2016-08), page 109, XP055488156, INTERNATIONAL CONGRESS OF IMMUNOLOGY (ICI); MELBOURNE, AUSTRALIA; AUGUST 21 -26, 2016 (B1)

JEROME BOYD-KIRKUP ET AL: "HMBD-002-V4: A novel anti-VISTA antibody that uniquely binds murine and human VISTA and potently inhibits tumor growth by remodeling the immunosuppressive tumor microenvironment", JOURNAL FOR IMMUNOTHERAPY OF CANCER, vol. 6, no. Suppl. 1, 6 November 2018 (2018-11-06), pages 248-249, XP055586880, (B1)

WO-A2-2015/097536 (B1)

LE MERCIER I ET AL: "VISTA regulates the development of protective antitumor immunity", CANCER RES,, vol. 74, no. 7, 1 January 2014 (2014-01-01), pages 1933-1944, XP002775903, DOI: 10.1158/0008-5472.CAN-13-1506 (B1)

LI WANG ET AL: "VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses", THE JOURNAL OF EXPERIMENTAL MEDICINE, vol. 208, no. 3, 7 March 2011 (2011-03-07) , pages 577-592, XP055387118, US ISSN: 0022-1007, DOI: 10.1084/jem.20100619 (B1)

PILONES K A ET AL: "Anti-VISTA Antibody Increases Tumor-Specific T Cells and Prolongs Survival of Metastatic Carcinoma-Bearing Mice Treated With Radiation Therapy, Cytoxan, and PD-1 Blockade", INTERNATIONAL JOURNAL OF RADIATION: ONCOLOGY BIOLOGY PHYSICS, vol. 99, no. 2, 1 October 2017 (2017-10-01), XP085191998, ISSN: 0360-3016, DOI: 10.1016/J.IJROBP.2017.06.301 (B1)

WO-A1-2014/039983 (B1)

WO-A1-2017/137830 (B1)

KATHY A. GREEN ET AL: "Selective Involvement of the Checkpoint Regulator VISTA in Suppression of B-Cell, but Not T-Cell, Responsiveness by Monocytic Myeloid-Derived Suppressor Cells from Mice Infected with an Immunodeficiency-Causing Retrovirus", JOURNAL OF VIROLOGY., vol. 89, no. 18, 8 July 2015 (2015-07-08), pages 9693-9698, XP055586768, US ISSN: 0022-538X, DOI: 10.1128/JVI.00888-15 (B1)